![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 297, Issue 3, 868-875, June 2001
in Signal Transduction of
Thrombopoietin in Enhancement of Interleukin-3-Dependent Proliferation
of Primitive Hematopoietic Progenitors
Third Department of Internal Medicine, Hokkaido University School
of Medicine (N.S., M.M., K.S., Y.T., S.O., T.M., M.A.); Health
Administration Center, Hokkaido University (M.M., K.S.); Department of
Biomedical Science, Graduate School of Veterinary Medicine (K.K.),
Hokkaido University; Sapporo Kosei Hospital (N.S., H.I.), Sapporo,
Japan; and Kirin Brewery Co., Ltd., Tokyo, Japan (T.K., H.M.,
A.S.)
We studied the effect of thrombopoietin (TPO) on interleukin-3
(IL-3)-dependent bone marrow cell colony formation of mice to clarify
the role of protein kinase C (PKC) in the signal transduction of TPO
for the proliferation of primitive hematopoietic progenitors. TPO alone
hardly yielded colonies. However, TPO in combination with IL-3
increased colony numbers synergistically from 2- to 4-fold, compared
with those supported by IL-3 alone. Serial observation of colony
development showed that TPO may hasten the appearance of colonies by
shortening the dormant period (G0) of primitive progenitors. Immunocytochemical studies on PKC isoforms in progenitor cells stimulated with TPO have revealed that the expression pattern of
PKC-
is changed, but not that of PKC-
, -
, -
, -
, or -
. Selective PKC inhibitors, such as calphostin C and GF 109203X, and PKC-
-specific translocation inhibitor peptide abrogated the enhancing effect of TPO on IL-3-dependent colony formation and the
changes in the intracellular expression pattern of PKC-
. These data
taken together suggest that TPO has a direct effect on primitive
progenitors and enhances IL-3-dependent colony formation, at least
partly through the activation of PKC-
.
This article has been cited by other articles:
![]() |
D. Campard, M. Vasse, S. Rose-John, F. Poyer, M. Lamacz, and J.-P. Vannier Multilevel Regulation of IL-6R by IL-6-sIL-6R Fusion Protein According to the Primitiveness of Peripheral Blood-Derived CD133+ Cells Stem Cells, May 1, 2006; 24(5): 1302 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mora-Garcia, J. Cheng, H. N. Crans-Vargas, A. Countouriotis, D. Shankar, and K. M. Sakamoto Transcriptional Regulators and Myelopoiesis: The Role of Serum Response Factor and CREB as Targets of Cytokine Signaling Stem Cells, March 1, 2003; 21(2): 123 - 130. [Abstract] [Full Text] [PDF] |
||||